Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

Mechanisms of Retrovirus-induced Cancers

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Programmed Death Ligand 1 (PD-L1) and Tumor-Associated Macrophages in Gastric-Type Hepatocellular Carcinoma: Prognostic Insights.

International journal of molecular sciences·2026

Same author

Immunohistochemical profiling of ampullary carcinoma: Molecular subtypes, prognostic markers, and the role of Claudin-18.

Virchows Archiv : an international journal of pathology·2026

Same author

Electrical and Functional Magnetic Stimulation in the Management of Children's Lower Urinary Tract Dysfunction-A Current Literature Review.

Children (Basel, Switzerland)·2026

Same author

<i>Coleophora cytisicolella</i> sp. nov., a new species (Lepidoptera, Coleophoridae), from Austria and Hungary bred from <i>Chamaecytisus austriacus</i>.

ZooKeys·2026

Same author

Assessment of the prevalence and consistency of microvascular flow imaging patterns in focal nodular hyperplasia.

Pathology oncology research : POR·2026

Same author

Vitamin D in Endocrine Disorders: A Broad Overview of Evidence in Musculoskeletal, Thyroid, Parathyroid, and Reproductive Disorders.

Pharmaceuticals (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: May 21, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

[MicroRNAs in hepatocarcinogenesis].

Gábor Lendvai¹, András Kiss, Ilona Kovalszky

¹Semmelweis Egyetem, Általános Orvostudományi Kar II. Patológiai Intézet Budapest Üllői út 93. 1091.

|June 21, 2012

Summary

MicroRNAs (miRNAs) show altered expression in liver diseases, including fibrosis, hepatitis, and hepatocellular carcinoma. These molecular changes in microRNAs (miRNAs) may serve as potential biomarkers for early detection and treatment monitoring.

More Related Videos

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Related Experiment Videos

Last Updated: May 21, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Area of Science:

Molecular Biology
Genetics
Hepatology

Context:

Hepatocarcinogenesis involves complex molecular alterations, with microRNAs (miRNAs) playing a significant regulatory role.
Altered miRNA expression is a hallmark of various liver diseases, including chronic hepatitis, fibrosis, and hepatocellular carcinoma (HCC).
Specific miRNAs, such as miR-21, miR-221, miR-222, miR-199a, and the liver-specific miR-122, exhibit characteristic expression changes across disease stages.

Purpose:

To summarize recent findings on microRNA (miRNA) expression alterations in distinct stages of hepatocarcinogenesis.
To highlight the role of miRNAs in liver diseases ranging from early fibrosis to advanced hepatocellular carcinoma.
To explore the potential of serum miRNAs as non-invasive biomarkers for liver disease diagnosis and progression.

Summary:

MicroRNA (miRNA) expression patterns are significantly altered in liver fibrosis, viral hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) compared to normal liver tissue.
miR-122, a liver-specific miRNA, shows decreased expression during liver injury and cancer progression and influences hepatitis C virus replication and therapy response.
Statistically significant differences in serum miRNA levels between patients with chronic hepatitis, cirrhosis, HCC, and healthy individuals suggest their utility as diagnostic biomarkers.

Impact:

Understanding miRNA alterations provides insights into the molecular mechanisms driving hepatocarcinogenesis.
Identification of specific miRNA signatures can aid in the early diagnosis and staging of liver diseases.
Serum miRNAs hold promise as novel, non-invasive biomarkers for monitoring liver disease progression and therapeutic efficacy.